A 3D atomic map, or structure, of the Gc protein (red and yellow) bound to two antibodies (green, blue and white) produced by a recovered CCHF patient. The Gc protein is a key molecule on the ...

Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus. ScienceDaily . Retrieved May 25, 2025 from www.sciencedaily.com / releases / 2022 / 11 ...

A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future. ... FIGURE 2: CCHFV virus structure. Bente et al.

The discovery of how the Crimean-Congo hemorrhagic fever virus enters human cells marks a significant advancement in our understanding of this deadly disease.

Crimean–Congo hemorrhagic fever (CCHF) caused by the CCHF virus, a member of the family Bunyaviridae, genus Nairovirus, is a tick-borne acute viral hemorrhagic fever with a high case–fatality ...

As far as emerging, zoonotic, viruses go—Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is one to watch. The disease, which is endemic in Africa, the Balkans, the Middle East, and some Asian ...

Highlights: The link between climate change and the emergence of the deadly Crimean-Congo haemorrhagic fever (CCHF) virus has become highly likely, with cases reported in Eastern Europe and France ...

A research team led by the University of California, Riverside, has discovered important details about how therapeutically relevant human monoclonal antibodies can protect against Crimean Congo ...